Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AMES Digital is a specialized digital health company based in Vienna, Austria, that develops innovative digital therapeutics (DTx) for neurological and musculoskeletal rehabilitation. The company's core technology is based on the AMES (Acoustic Muscle Stimulation) method, which integrates synchronized vibratory muscle stimulation with visual biofeedback to facilitate neuroplasticity and motor recovery. This approach is specifically designed to treat patients with significant motor impairments resulting from stroke, spinal cord injuries, and multiple sclerosis. By providing a platform for intensive, home-based rehabilitation, AMES Digital aims to bridge the gap between clinical treatment and long-term recovery. Their solutions are built on clinical research into sensory-motor integration and are focused on improving functional independence for patients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AMES Digital.